JB Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-49,697
Closed -$3.53M 216
2023
Q3
$3.53M Buy
49,697
+3,436
+7% +$257K 0.3% 47
2023
Q2
$3.56M Buy
46,261
+2,267
+5% +$175K 0.3% 55
2023
Q1
$3.31M Buy
43,994
+3,998
+10% +$297K 0.3% 56
2022
Q4
$3.15M Buy
39,996
+3,585
+10% +$269K 0.31% 60
2022
Q3
$2.56M Buy
36,411
+4,209
+13% +$330K 0.28% 59
2022
Q2
$2.58M Buy
32,202
+3,739
+13% +$292K 0.28% 44
2022
Q1
$2.16M Buy
28,463
+2,040
+8% +$162K 0.21% 54
2021
Q4
$2.25M Buy
26,423
+1,931
+8% +$151K 0.22% 58
2021
Q3
$1.85M Buy
+24,492
New +$1.94M 0.24% 62

Other funds holding CL

JB Capital's CL Position: Q4 2023 in Review

JB Capital sold out of Colgate-Palmolive (CL) in Q4 2023, closing a stake of 49,697 shares — an estimated $3.53M sold.

JB Capital first reported a position in CL in Q3 2021 and held it in 9 quarters. The position peaked at $3.56M in Q2 2023. 1,740 funds tracked by Wall St. Rank hold CL as of Q4 2023.

  • JB Capital reported no remaining Colgate-Palmolive position as of Q4 2023 after selling out during the quarter.
  • JB Capital sold 49,697 Colgate-Palmolive shares in Q4 2023, an estimated $3.53M.
  • JB Capital first reported a position in Colgate-Palmolive in Q3 2021 and held it in 9 quarters.
  • JB Capital's Colgate-Palmolive position peaked at $3.56M in Q2 2023.
  • 1,740 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2023.

Based on JB Capital's 13F filing for Q4 2023, filed 22 Jan 2024.